Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE”

783 pharma patents match "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 783
Index total 30,257
Page 16 / 33

Quick answer

This filtered view shows 783 pharmaceutical patents matching "THE UNITED STATES OF AMERICA AS REPRESENTED BY THE" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

783 results for “THE UNITED STATES OF AMERICA AS REPRESENTED BY THE” · 30,257 patents in full index Clear search

  1. US 8298546

    Isolation and purification of P. falciparum merozoite protein-142 vaccine

    The United States of America as represented by the Secretary of the Army · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted
  2. US 8298525

    Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted
  3. US 8288359

    Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  4. US 8282926

    CCR5-specific antibodies with HIV neutralizing activity that recognize a linear dodecapeptide that mimics a conformational epitope in the second extracellular loop of CCR5

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted
  5. US 8283370

    Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use

    The United States of America as represented by the Secretary of the Army · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted
  6. US 8278100

    Lasonolide compounds as reagents for inducing premature chromosome condensation and methods for treating disorders

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted
  7. US 8278348

    Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted
  8. US 8278083

    Inactivated influenza virus compositions

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted
  9. US 8273797

    Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted
  10. US 8268615

    Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide

    The United States of America as represented by the Secretary of the Army · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  11. US 8268323

    Conformationally stabilized HIV envelope immunogens

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  12. US 8263091

    Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  13. US 8258280

    Plasmodium vivax hybrid circumsporozoite protein and vaccine

    The United States of America as represented by the Secretary of the Army · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  14. US 8257915

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted
  15. US 8252538

    MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  16. US 8252550

    Targeting poly-γ-glutamic acid to treat Staphylococcus epidermidis and related infections

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  17. US 8247228

    Method of inducing memory B cell development and terminal differentiation

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  18. US 8247183

    Compositions and methods for diagnosis and treatment of tumors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  19. US 8236313

    Prevention of tissue ischemia, related methods and compositions

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  20. US 8232259

    Multiple CpG oligodeoxynucleotide and their use to induce an immune response

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  21. US 8232379

    Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  22. US 8227446

    Oligodeoxynucleotide and its use to induce an immune response

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  23. US 8227438

    Suppressors of CpG oligonucleotides and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  24. US 8221768

    Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted